Robinhood HOOD Stock Surges As Wall Street Turns Bullish
Robinhood Markets Inc. (HOOD) stock surged 15.9% on September 3, 2026, driven by retail trading and crypto-driven user growth. The stock has risen from around $94 in late August to near $124.72. Analysts from Morgan Stanley, Scotiabank, and Piper Sandler have issued bullish calls, citing expanded product offerings and strong growth prospects. HOOD reported revenue of $4.47B over the last year, with a P/E ratio of 45.8 and a price-to-sales ratio of 18.9.
How this was made

The 30-second read
Why it matters
The upgrades provide a fresh catalyst that could sustain the price rally, but high valuation multiples and leverage remain concerns.
Market read
HOOD's intraday surge and fresh analyst upgrades make it a near‑term trading opportunity, especially for momentum traders.
What to watch
Regulatory scrutiny of prediction markets and potential earnings volatility from rapid growth could temper upside.
Background
Robinhood's stock jumped sharply amid a wave of analyst upgrades and a surge in retail and crypto trading activity.
Ticker impact
Robinhood Markets Inc. stock surged 15.9% intraday after multiple analyst upgrades and price‑target raises released today.
Potential continuation of bullish momentum; target zone $130‑$140 in the short term.
Analyst upgrades from Morgan Stanley, Scotiabank and Piper Sandler are fresh and accompanied by higher price targets, providing a clear catalyst for traders.
Market effects
Retail brokerage and crypto‑exposed platforms may see broader buying pressure as sentiment improves.
U.S. equity markets benefit from heightened retail trading activity.
Limited to U.S. markets; no direct global macro impact.
Counterpoint
The rally may be overextended; high leverage and thin interest coverage pose downside risk if crypto volatility spikes.
Key entities
- AnalystMorgan Stanley
Upgraded Robinhood to Overweight and raised price target to $150.
- AnalystScotiabank
Initiated coverage with Outperform rating and $136 target.
- AnalystPiper Sandler
Raised target to $145, maintaining Overweight.




